121 related articles for article (PubMed ID: 38784338)
1. Intra-arterial Chemotherapy in Patients With Metastatic Breast Cancer: A Scoping Review.
Basra M; Patel H; Biglione A
Cureus; 2024 Apr; 16(4):e58846. PubMed ID: 38784338
[TBL] [Abstract][Full Text] [Related]
2. Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials.
Liu F; Tang Y; Sun J; Yuan Z; Li S; Sheng J; Ren H; Hao J
PLoS One; 2012; 7(7):e40847. PubMed ID: 22815840
[TBL] [Abstract][Full Text] [Related]
3. Regional intra-arterial vs. systemic chemotherapy for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis.
Cao Y; Yu D; Wu Y; Zhu W
Front Oncol; 2024; 14():1197424. PubMed ID: 38651152
[TBL] [Abstract][Full Text] [Related]
4. Effect of multiple-phase regional intra-arterial infusion chemotherapy on patients with resectable pancreatic head adenocarcinoma.
Jin C; Yao L; Long J; Fu DL; Yu XJ; Xu J; Yang F; Ni QX
Chin Med J (Engl); 2009 Feb; 122(3):284-90. PubMed ID: 19236805
[TBL] [Abstract][Full Text] [Related]
5. Docetaxel: a new active agent in the therapy of metastatic breast cancer.
Fumoleau P; Seidman AD; Trudeau ME; Chevallier B; Ten Bokkel Huinink WW
Expert Opin Investig Drugs; 1997 Dec; 6(12):1853-65. PubMed ID: 15989586
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Arterial Infusion Chemotherapy for Metastatic Breast Cancer Patients With Resistance to Standard Systemic Chemotherapies.
Furuta M; Watanabe J; Aramaki T; Notsu A; Yasui H
In Vivo; 2020; 34(1):275-282. PubMed ID: 31882489
[TBL] [Abstract][Full Text] [Related]
7. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
8. Complete response in a patient with liver metastases from breast cancer employing hepatic arterial infusion 5-fluorouracil based chemotherapy plus systemic nab-paclitaxel.
Ranieri G; Marech I; Porcelli M; Giotta F; Palmiotti G; Laricchia G; Fazio V; Gadaleta CD
Oncotarget; 2018 Jan; 9(8):8197-8203. PubMed ID: 29487726
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy.
Qian JY; Tan YL; Zhang Y; Yang YF; Li XQ
Oncol Lett; 2018 Jul; 16(1):1253-1258. PubMed ID: 29963198
[TBL] [Abstract][Full Text] [Related]
10. Improved Survival in Patients with Resected Pancreatic Carcinoma Using Postoperative Intensity-Modulated Radiotherapy and Regional Intra-Arterial Infusion Chemotherapy.
Ma N; Wang Z; Zhao J; Long J; Xu J; Ren Z; Jiang G
Med Sci Monit; 2017 May; 23():2315-2323. PubMed ID: 28512284
[TBL] [Abstract][Full Text] [Related]
11. Arterial chemotherapy in the management of colorectal cancer: an overview.
Patt YZ; Mavligit GM
Semin Oncol; 1991 Oct; 18(5):478-90. PubMed ID: 1925634
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial hepatic bevacizumab and systemic chemotherapy in hepatic metastasis of colorectal cancer: A phase II multicentric trial in second-line treatment.
Rigault E; Lacas B; Glehen O; Smith D; Dupont-Bierre E; Guimbaud R; Malka D; Boige V; Fuerea A; Pignon JP; Ducreux M
Cancer Treat Res Commun; 2023; 34():100674. PubMed ID: 36565566
[TBL] [Abstract][Full Text] [Related]
13. INTRA-ARTERIAL CHEMOTHERAPY AS A CLINICAL OPTION FOR METASTATIC COLORECTAL CANCER: CONVERSION OF INOPERABLE LIVER METASTASES TO OPERABLE ILLUSTRATED WITH A CLINICAL CASE.
Cherchenko K; Lukashenko A; Ostapenko Y; Patsko V; Vinohradova M; Valikhnovska K; Pamanska S
Exp Oncol; 2024 Feb; 45(4):515-522. PubMed ID: 38328838
[TBL] [Abstract][Full Text] [Related]
14. Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.
Cercek A; Boucher TM; Gluskin JS; Aguiló A; Chou JF; Connell LC; Capanu M; Reidy-Lagunes D; D'Angelica M; Kemeny NE
J Surg Oncol; 2016 Nov; 114(6):655-663. PubMed ID: 27566258
[TBL] [Abstract][Full Text] [Related]
15. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
16. Sorbitol removal by the metastatic liver: a predictor of systemic toxicity of intra-arterial chemotherapy in patients with liver metastases.
Bar F; Battista S; Bucchi MC; Zanon C; Grosso M; Alabiso O; Miraglia S; Cappello N; Gariboldi A; Molino G
J Hepatol; 1999 Jun; 30(6):1112-8. PubMed ID: 10406191
[TBL] [Abstract][Full Text] [Related]
17. HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients.
Ning Z; Xie J; Chen Q; Zhang C; Xu L; Song L; Meng Z
Onco Targets Ther; 2019; 12():1021-1029. PubMed ID: 30774386
[TBL] [Abstract][Full Text] [Related]
18. Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.
Goi T; Naruse T; Kimura Y; Fujimoto D; Morikawa M; Koneri K; Yamaguchi A
World J Surg Oncol; 2015 Oct; 13():296. PubMed ID: 26452624
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
Bhutiani N; Akinwande O; Martin RC
World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
[TBL] [Abstract][Full Text] [Related]
20. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases.
Kingham TP; D'Angelica M; Kemeny NE
J Surg Oncol; 2010 Dec; 102(8):988-95. PubMed ID: 21166003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
